Study Stopped
Due to COVID-19, recruitment and enrollment was suspended and never resumed. COVID-related changes have been made to the clinical program which houses our intervention, and we could not compare new participants with our previous cohort.
Lifestyle, Exercise and Diet: The LEAD Study
LEAD
Nutrition, Exercise and Lifestyle: Team 6 of the Canadian Consortium on Neurodegeneration in Aging (CCNA)
1 other identifier
interventional
14
1 country
4
Brief Summary
This study will explore the impact of an exercise and nutrition (EX+NUTR) , relative to exercise alone (EX) intervention, on brain structure and function as well as blood biomarkers in older adults with subjective cognitive decline (SCD) and vascular risk factors. The overall hypotheses are that a combined EX+NUTR, relative to EX, intervention will evoke more positive changes in brain structure (e.g. hippocampal volume), neural activity (e.g. task associated functional activations monitored through fMRI), and cognitive performance. These changes will be associated with an improved metabolic profile, reductions in inflammatory cytokines and oxidative burden, and greater intervention compliance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2018
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2017
CompletedFirst Posted
Study publicly available on registry
February 17, 2017
CompletedStudy Start
First participant enrolled
July 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 8, 2020
CompletedOctober 14, 2020
October 1, 2020
2.3 years
February 9, 2017
October 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes from baseline brain structure at 6 months and 12 months.
Cortical and subcortical grey matter density using MRI three-dimensional T1 weighted structural scan (MPRAGE)
6 months plus 6 month follow-up
Secondary Outcomes (20)
Changes from baseline cerebral blood flow at 6 months and 12 months.
6 months plus 6 month follow-up
Changes from baseline cognition at 6 months and 12 months
6 months plus 6 month follow-up
Changes from baseline brain activity related to attention at 6 months and 12 months
6 months plus 6 month follow-up
Changes from baseline resting state connectivity at 6 months and 12 months
6 months plus 6 month follow-up
Changes from baseline diet quality at 6 months and 12 months
6 months plus 6 month follow-up
- +15 more secondary outcomes
Study Arms (2)
Exercise plus Nutrition
EXPERIMENTAL6 months of supervised group exercise plus education and strategy training to alter diet to be consistent with recommendations outlined in our brain health food guide (BHFG).
Exercise
ACTIVE COMPARATORIdentical exercise to the experimental plus education and passive discussion about brain health and healthy lifestyle to control for experimental group nutrition sessions.
Interventions
On the same day as the exercise class, participants will also receive nutrition support. Participants will alter their overall diet to be consistent with recommendations outlined in our brain health food guide (BHFG) and receive diet counseling and strategy training to promote retention and enable this dietary change. For the first two months, diet group sessions will be held on a weekly basis. For the remaining four months, sessions will be divided between group sessions and individual meetings with study dietitians, on a predefined schedule. Participants will submit weekly logs outlining diet goals, plans, successes and obstacles to help direct identification of sequential goals.
Supervised group exercise will be performed once per week (60 minutes) and self-directed exercise (4 additional aerobic and 2-3 resistance training sessions per week) will be monitored by an exercise diary. The initial walking prescription will be set at \~1.6 km and an intensity equivalent to the anaerobic threshold and/or 60% VO2-peak. Progressions will be made every 2 weeks, increasing distance to a maximum of 6.4 km and then increasing to a max intensity of 80% of VO2-peak and/or max duration of 60 minutes. Heart rate and perceived exertion will be monitored. The program will last 6 months.
Eligibility Criteria
You may qualify if:
- meeting criteria for subjective cognitive impairment (1 through 5 below)
- Answer Yes to both following questions:
- Do you feel like your memory or thinking is becoming worse?
- Does this concern you?
- Have a delayed recall score on 1 paragraph of the Logical Memory test (Wechsler Memory Scale, maximum score 25) above the education-adjusted cut-offs:
- ≥9 for 16+ years of education;
- ≥5 for 8-15 years of education;
- ≥3 for 0-7 years of education.
- Have a Montreal Cognitive Assessment (MoCA) total score of 20 and over (≥20/30).
- Have a delayed recall score on the CERAD word list of 5 and over (≥5).
- Have a global Clinical Dementia Rating score (CDR) equal to 0.5 or less (≤0.5).
- ≥2 vascular risk factors (overweight (BMI\>25), T2DM, hypercholesterolemia or hypertension),
- Consuming a poor quality diet (at least median or below on number of servings of vegetable, fruit, fish and nuts based on Canadian consumption patterns in older adults)
- Reasonably sedentary (less than 75min per week of moderate - vigorous intensity physical activity)
- Be available for the whole intervention (6 months) and a 12- month follow-up visit
- +1 more criteria
You may not qualify if:
- The presence of significant known chronic brain disease such as: moderate to severe chronic static leukoencephalopathy (including previous traumatic injury), multiple sclerosis, a serious developmental handicap, malignant tumors, Parkinson's disease, and other rarer brain illnesses.
- Ongoing alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures.
- Subject does not have a study partner who can provide corroborative information.
- Symptomatic stroke within the previous year.
- Unable to undergo MRI scan due to medical contraindications or inability to tolerate the procedure.
- Major surgery within last 2 months.
- History of intracranial surgery
- Serious comorbid condition that, in the opinion of the study investigator, is likely to result in death within a year.
- High performance athletes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rotman Research Institute at Baycrestlead
- Sunnybrook Health Sciences Centrecollaborator
- Toronto Rehabilitation Institutecollaborator
- The Centre for Memory and Agingcollaborator
- University of Waterloocollaborator
Study Sites (4)
Toronto Rehabilitation Institute Rumsey Centre
Toronto, Ontario, M4G 2V6, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
Rotman Research Institute
Toronto, Ontario, M6A 2E1, Canada
Centre for Community, Clinical Applied Research Excellence (CCCARE) at the University of Waterloo
Waterloo, Ontario, Canada
Related Publications (1)
Koblinsky ND, Anderson ND, Ajwani F, Parrott MD, Dawson D, Marzolini S, Oh P, MacIntosh B, Middleton L, Ferland G, Greenwood CE. Feasibility and preliminary efficacy of the LEAD trial: a cluster randomized controlled lifestyle intervention to improve hippocampal volume in older adults at-risk for dementia. Pilot Feasibility Stud. 2022 Feb 9;8(1):37. doi: 10.1186/s40814-022-00977-6.
PMID: 35139918DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carol E Greenwood, PhD
Rotman Research Institute Baycrest Health Sciences
- PRINCIPAL INVESTIGATOR
Nicole D Anderson, PhD
Rotman Research Institute Baycrest Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Scientist
Study Record Dates
First Submitted
February 9, 2017
First Posted
February 17, 2017
Study Start
July 1, 2018
Primary Completion
October 8, 2020
Study Completion
October 8, 2020
Last Updated
October 14, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will share
data will be uploaded to shared CCNA database - LORIS